Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-14

Clinical Trial Update: Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating zoledronic acid after denosumab in osteoporosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denosumab (denosumab)
  • Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2021-01-14